<DOC>
	<DOCNO>NCT01064882</DOCNO>
	<brief_summary>This study evaluate safety efficacy bimatoprost ophthalmic solution 0.005 % 0.015 % compare bimatoprost ophthalmic solution 0.03 % once-daily application upper eyelid margin increase eyelash prominence</brief_summary>
	<brief_title>Safety Efficacy Bimatoprost Ophthalmic Solution Increasing Eyelash Prominence</brief_title>
	<detailed_description />
	<mesh_term>Hypotrichosis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Female Caucasians 30 55 year age , hypotrichosis ( inadequate enough ) eyelashes Eyelash prominence assessment minimal moderate Any eye disease abnormality Any permanent eyeliner eyelash implant kind Any ocular surgery , semipermanent eyelash tint , eyelash extension application 3 month prior study entry Any use prescription eyelash growth product Any use counter eyelash growth product 6 month prior baseline Any use treatment may affect hair growth 6 month prior baseline</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>